Rare Medical News

Advertisement

Spotlight On

Infantile neuroaxonal dystrophy

Infantile neuroaxonal dystrophy is a type of lipid storage disorder that mostly affects the nervous system. It has two forms, a classic form and an atypical form.

Prevalence

unknown

N/A

US Estimated

N/A

Europe Estimated

Age of Onset

Infancy

ageofonset infancy https://raremedicalnews.com/wp-content/uploads/2025/08/Depositphotos_665910484_S.jpg

ICD-10

G23.0

Inheritance Pattern

Autosomal recessive

rnn autosomalrecessive https://raremedicalnews.com/wp-content/uploads/2025/08/Depositphotos_665910484_S.jpg

5 Facts you should know

FACT

1

Infantile neuroaxonal dystrophy (INAD) is a progressive, autosomal recessive neurodegenerative disorder most often caused by pathogenic variants in the PLA2G6 gene, leading to abnormal phospholipid metabolism and axonal spheroid formation

FACT

2

Onset usually occurs in the first 2 years of life with developmental regression, hypotonia, loss of motor milestones, and rapid progression to spasticity and profound neurologic disability

 

FACT

3

Ophthalmologic findings such as optic atrophy, nystagmus, and strabismus are common and often serve as early diagnostic clues alongside motor decline

FACT

4

Brain MRI typically demonstrates cerebellar atrophy, white matter changes, and iron accumulation in the globus pallidus and substantia nigra, features consistent with the neurodegeneration with brain iron accumulation (NBIA) spectrum

FACT

5

There is currently no curative treatment; management is supportive and multidisciplinary, including seizure control, physical therapy, nutritional support, and assistive care. Prognosis is poor, with many affected children not surviving beyond the first or second decade of life

Infantile neuroaxonal dystrophy is also known as...

Infantile neuroaxonal dystrophy is also known as:

  • PLA2G6-Associated Neurodegeneration

  • Seitelberger’s Disease

What’s your Rare IQ?

At what age do symptoms of Infantile Neuroaxonal Dystrophy typically begin?

Common signs & symptoms

Developmental regression

Muscular hypotonia

Optic atrophy

Seizures

Loss of purposeful hand use

Neurodegeneration due to iron accumulation in the brain

Current treatments

Supportive and symptomatic care

  • Seizure management

  • Physical and occupational therapy

  • Nutritional support and mobility aids

Palliative care approaches for advanced stages

No curative treatment currently available